WebTAGRISSO is available for purchase from these authorized Specialty Distributors: AMERISOURCEBERGEN ASD Healthcare p: 1-800-746-6273 f: 1-800-547-9413 … WebOn December 18, 2024, the Food and Drug Administration approved osimertinib (TAGRISSO, AstraZeneca Pharmaceuticals LP) for adjuvant therapy after tumor resection in patients …
Contact Us – TAGRISSO® (osimertinib)
WebThis website will guide you through a simple application process to see if you are eligible for the AZ&Me Prescription Savings Program. We have made it simple to apply online—you … WebYou can also enroll yourself by contacting AstraZeneca Access 360 TM at 1-844-ASK-A360 ( 1-844-275-2360) (1-844-275-2360) . If you meet the program eligibility criteria, a Patient Savings Program account will be created for you. You will pay a set amount of your out-of-pocket costs, based on the product, and your pharmacy or healthcare provider ... challenger homes monument co
FDA approves osimertinib as adjuvant therapy for non-small cell …
WebApr 12, 2024 · Contact; Menu. Dann's Cancer Chronicles. Street Address. City, State, Zip. Phone Number. Lung cancer survivor's stories of hope and success. Your Custom Text Here. Dann's Cancer Chronicles. Blog; Faces; ... Tagrisso success stories, lung cancer attitude, lung cancer clinical trials. Featured. WebMost eligible patients will pay as little as $0 per month and may have access to up to $26,000 per year to assist with TAGRISSO out-of-pocket costs. There are no income requirements to participate in the program. Visit www.astrazenecaspecialtysavings.com or call 1-844-ASK-A360 (1-844-275-2360) for more information. WebTAGRISSO is a prescription drug approved for the treatment of EGFR+ NSCLC to help prevent your lung cancer from coming back after surgery. In a clinical trial, TAGRISSO significantly lowered the chance of EGFR+ non-small cell lung cancer coming back after surgery. In this trial, Stage 2 and 3A EGFR+ NSCLC patients receiving TAGRISSO following … challenger homes mountain vista